29
Participants
Start Date
December 16, 2021
Primary Completion Date
August 7, 2023
Study Completion Date
August 7, 2023
Ruxolitinib cream
Ruxolitinib 1.5% cream applied twice daily.
Forest Hills Dermatology Group, Forest Hills
Advanced Medical Research Pc, Sandy Springs
Aeroallergy Research Lab of Savannah, Savannah
Accel Clinical Research, Lake Mary
San Marcus Research Clinic Inc., Miami Lakes
Skin Care Research, Llc Scr Hollywood, Hollywood
Forward Clinical Trials, Tampa
Ohio Pediatric Research Association, Dayton
Oakland Hills Dermatology Pc, Auburn Hills
Burke Pharmaceutical Research, Hot Springs
Progressive Clinical Research, San Antonio
Desert Sky Dermatology, Gilbert
Skin Cancer and Dermatology Institute, Reno
Orange County Research Center, Anaheim
Cyn3Rgy Research - Clinedge - Ppds, Gresham
Lead Sponsor
Collaborators (1)
Innovaderm Research
UNKNOWN
Incyte Corporation
INDUSTRY